Trade CRIS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Curis, Inc. (CRIS) is trading at US$0.41, down 19.86% today as of Oct 16, 16:00 EDT. The company has a market capitalisation of US$3.83M. Over the past 52 weeks, CRIS has traded between US$0.33 and US$33.60. On Syfe you can trade CRIS with $0 commission and add it to your watchlist.
| Previous close | US$0.51 |
|---|---|
| Market cap | US$3.83M |
| 52-week range | US$0.33 – US$33.60 |
| Volume | 1.31M |
| Exchange | US |
Curis, Inc.
Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.
Year: 2000
Curis Prices $5.6 Million Public Offering With Healthcare-Focused Institutional Investors
Aug 13, 1:28 PM · MT Newswires
Curis Consents 6 Patients in Phase 2 Trial of Emavusertib in Chronic Lymphocytic Leukemia
Jul 6, 2:11 PM · MT Newswires
Curis, Inc. (CRIS) stock is trading at US$0.41, -19.86% from the previous close of US$0.51.
The market cap for Curis, Inc. (CRIS) stock is approximately US$3.83M.
The 52-week high for Curis, Inc. (CRIS) stock is US$33.60.
The 52-week low for Curis, Inc. (CRIS) stock is US$0.33.
Curis, Inc. (CRIS) does not currently pay a dividend.
Stay on top of CRIS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
